In the search for multi-target drugs for MetS, microbial sources like probiotic bacteria, soil actinomycetes, and endophytic fungi are being increasingly recognized not only for their ability to modulate GLP-1 but also for their emerging role in regulating oxidative stress through the TXNIP–thioredoxin system. The gene discussed is GLP1R; the disease is metabolic syndrome.